Significant clinical response to a MEK inhibitor therapy in a patient with metastatic melanoma harboring an RAF1 fusion

Kevin B. Kim, Thomas Semrad, Alexa B. Schrock, Siraj M. Ali, Jeffrey S. Ross, Mark Singer, Mohammed Kashani-Sabet

Research output: Contribution to journalArticlepeer-review

11 Scopus citations
Original languageEnglish (US)
JournalJCO Precision Oncology
Volume2
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this